Seeking Alpha

Jazz Pharmaceuticals (JAZZ): Q4 EPS of $1.17 beats by $0.08. Revenue of $83.5M (+56.4% Y/Y)...

Jazz Pharmaceuticals (JAZZ): Q4 EPS of $1.17 beats by $0.08. Revenue of $83.5M (+56.4% Y/Y) beats by $3M. Shares +2.3% AH. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)